These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20202121)

  • 21. [Phenotypes in ALS--clinical features and pathology].
    Sasaki S
    Brain Nerve; 2007 Oct; 59(10):1013-21. PubMed ID: 17969341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of motor neuron disease: the challenge is in the genes.
    Veldink JH; Van den Berg LH; Wokke JH
    J Neurol; 2004 Apr; 251(4):491-500. PubMed ID: 15083302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about 'ongoing change and adaptation'.
    King SJ; Duke MM; O'Connor BA
    J Clin Nurs; 2009 Mar; 18(5):745-54. PubMed ID: 19239541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Far-field and cortical somatosensory evoked potentials in motor neuron disease.
    Zanette G; Polo A; Gasperini M; Bertolasi L; De Grandis D
    Muscle Nerve; 1990 Jan; 13(1):47-55. PubMed ID: 2325701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central motor conduction in motor neuron disease.
    Misra UK; Mathur VN; Kalita J
    Electromyogr Clin Neurophysiol; 1995 Dec; 35(8):485-90. PubMed ID: 8773209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic stimulation in ALS--a single motor unit study.
    Kohara N; Kaji R; Kojima Y; Hamano T; Fujii H; Katayama M; Hirota N; Kimura J
    Electroencephalogr Clin Neurophysiol Suppl; 1996; 46():327-36. PubMed ID: 9059808
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity-driven synaptic and axonal degeneration in canine motor neuron disease.
    Carrasco DI; Rich MM; Wang Q; Cope TC; Pinter MJ
    J Neurophysiol; 2004 Aug; 92(2):1175-81. PubMed ID: 15028742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic disorders of motor neurons.
    Cole N; Siddique T
    Semin Neurol; 1999; 19(4):407-18. PubMed ID: 10716663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distal latency in motor neuron disease].
    Bedenić B; Filipusić D
    Neurologija; 1990; 39(4):273-84. PubMed ID: 2290473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease.
    Rich MM; Wang X; Cope TC; Pinter MJ
    J Neurophysiol; 2002 Dec; 88(6):3305-14. PubMed ID: 12466448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease.
    Christou YA; Moore HD; Shaw PJ; Monk PN
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):485-98. PubMed ID: 17854436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blink reflex in motor neuron disease.
    Szmidt-Sałkowska E; Rowińska-Marcińska K
    Electromyogr Clin Neurophysiol; 2005; 45(5):313-7. PubMed ID: 16218200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal model of human disease: motor neuron disease: spinal muscular atrophy and amyotrophic lateral sclerosis.
    Cork LC; Griffin JW; Adams RJ; Price DL
    Am J Pathol; 1980 Aug; 100(2):599-602. PubMed ID: 7406024
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology.
    Short CL; Scott G; Blumbergs PC; Koblar SA
    J Clin Neurosci; 2005 Aug; 12(6):706-9. PubMed ID: 16098753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiology of alpha motoneurons and their synaptic input in relation to the problem of amyotrophic lateral sclerosis.
    Burke RE
    UCLA Forum Med Sci; 1976; (19):119-33. PubMed ID: 15338
    [No Abstract]   [Full Text] [Related]  

  • 37. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptic dysfunction in disease and following injury in the developing and adult nervous system: caveats in the choice of therapeutic intervention.
    Gould TW; Oppenheim RW
    Neurosci Biobehav Rev; 2007; 31(8):1073-87. PubMed ID: 17573112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrophysiologic assessment in motor neuron diseases].
    Espadaler-Gamissans JM
    Neurologia; 1996 Dec; 11 Suppl 5():20-8. PubMed ID: 9044571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.